MAZE
Maze Therapeutics, Inc.
26.20$
-6.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | – | – | – | – | – | 100.0% | – | 100.0% | |
| – | – | – | – | 31.5% | – | – | – | – | – | 2.2% | – | – | |
| – | – | – | 100.0% | 100.0% | – | – | – | – | – | 97.8% | – | – | |
| – | – | – | 11.8% | 794.3% | – | – | – | – | – | 168.5% | – | 607.0% | |
| – | – | – | 3.6% | 274.9% | – | – | – | – | – | 62.0% | – | 218.8% | |
| – | – | – | 15.4% | 1,069.2% | – | – | – | – | – | 230.5% | – | 823.3% | |
| – | – | – | 84.6% | -969.2% | – | – | – | – | – | -132.8% | – | -728.1% | |
| – | – | – | – | – | – | – | – | – | – | 4.3% | – | – | |
| – | – | – | 85.3% | -1,001.2% | – | – | – | – | – | -121.0% | – | -668.0% | |
| – | – | – | 1.0% | -11.2% | – | – | – | – | – | – | – | – | |
| – | – | – | 84.3% | -990.1% | – | – | – | – | – | -121.0% | – | -668.0% | |
| – | – | – | 85.8% | -969.7% | – | – | – | – | – | -114.5% | – | -651.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.